Search for: "State v. Lilly" Results 161 - 180 of 918
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Apr 2018, 3:42 am by Brian Cordery
Interestingly, in light of the Supreme Court decision in Actavis v Lilly having been handed down after the first instance judgment in the present proceedings, Regeneron appears to have argued that even if Kymab was right on construction, there was still infringement under the newly-conceived English law doctrine of equivalents. [read post]
20 Mar 2018, 10:59 am
Never Too Late 183 [week ending 18 February] Mr Justice Carr's L'Oreal v RN Ventures decision bristles with warnings on Actavis v Lilly claim interpretation, equivalents and prosecution history (Parts I and II) | Can Wenzhou and cigarette lighters tell us something about why there are IP rights? [read post]
8 Mar 2018, 6:48 am
Following Actavis vs Eli Lilly, is the UK becoming more author-centric? [read post]
1 Mar 2018, 6:38 am
PREVIOUSLY ON NEVER TOO LATENever Too Late 183 [week ending 18 February] Mr Justice Carr's L'Oreal v RN Ventures decision bristles with warnings on Actavis v Lilly claim interpretation, equivalents and prosecution history (Parts I and II) | Can Wenzhou and cigarette lighters tell us something about why there are IP rights? [read post]
22 Feb 2018, 8:55 am
If last year’s Supreme Court case in Actavis v Eli Lilly is to be taken as a guide, the Court may take around three months to make its judgment available. [read post]
21 Feb 2018, 1:48 am
PatentsIn a two-part report, the AmeriKat exfoliates the decision in L'Oreal v RN Ventures [2018] EWHC 173, in which Mr Justice Carr bristles with warnings on Actavis v Lilly claim interpretation, equivalents and prosecution history (Part I and Part II)Can Wenzhou and cigarette lighters tell us something about why there are IP rights? [read post]
17 Feb 2018, 7:31 am
  The use of prosecution history must support at least one of the two instances identified by Lord Neuberger in Actavis v Lilly. [read post]
17 Feb 2018, 7:30 am
”Henry loved when he was in "shear mode"Claim "Interpretation"  - it is all about what you say and disclaimWith the old "Construction" heading now replaced with "Interpretation", Mr Justice Carr stated he would be applying"principles concerning normal interpretation and equivalents set out by the Supreme Court in Actavis v Eli Lilly [2017] UKSC 48, [2018] and by the Patents Court in Mylan v Yeda [2017] EWHC… [read post]
5 Feb 2018, 7:23 am by William Ford
Robert Joseph, the former under secretary of state for arms control, Thomas Karako, and Bilyana Lilly. [read post]
31 Jan 2018, 10:05 pm
  Article 3(a):  a spectrum of specificity The Court of Appeal reviewed the case law of the CJEU and pending references, focussing on Case C-322/10 Medeva BV v Comptroller-General of Patents, Designs and Trade Marks and Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc. [read post]
31 Jan 2018, 8:13 pm by Florian Mueller
Ragan, a discovery expert, and Orrick's Alyssa Caridis, an IP lawyer from a family of inventors.The brief notes that Qualcomm is seeking similar sanctions against other non-parties that have been told to produce documents in connection with FTC v. [read post]
29 Jan 2018, 2:57 am
 The UCL debate on the UK Supreme Court decision Actavis v Eli Lilly ("Equivalents: K = Na. [read post]
19 Jan 2018, 3:58 am
Readers interested in patent law will be familiar with last summer's decision of the UK Supreme Court in Actavis v Eli Lilly [2017] UKSC 48. [read post]
1 Dec 2017, 6:20 am
The panel discussion was on the doctrine of equivalents following the Actavis v Lilly decision. [read post]